BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 12672403)

  • 21. [CD40L expression on T CD4+ lymphocytes from peripheral blood in patients with relapsing-remitting and secondary progressive multiple sclerosis].
    Bilińska M; Frydecka I; Kosmaczewska A; Ciszak L; Koszewicz M; Pokryszko-Dragan A
    Pol Merkur Lekarski; 2006 Jan; 20(115):41-5. PubMed ID: 16617733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinct chemokine receptor and cytokine expression profile in secondary progressive MS.
    Sørensen TL; Sellebjerg F
    Neurology; 2001 Oct; 57(8):1371-6. PubMed ID: 11673573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dysregulation of B7.2 (CD86) expression on monocytes of HIV-infected individuals is associated with altered production of IL-2.
    Kumar A; Angel JB; Aucoin S; Creery WD; Daftarian MP; Cameron DW; Filion L; Diaz-Mitoma F
    Clin Exp Immunol; 1999 Jul; 117(1):84-91. PubMed ID: 10403920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered expression of costimulatory molecules in myasthenia gravis.
    Teleshova N; Matusevicius D; Kivisäkk P; Mustafa M; Pirskanen R; Link H
    Muscle Nerve; 2000 Jun; 23(6):946-53. PubMed ID: 10842273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Replicative response, immunophenotype, and functional activity of monocyte-derived versus CD34(+)-derived dendritic cells following exposure to various expansion and maturational stimuli.
    Chen B; Stiff P; Sloan G; Kash J; Manjunath R; Pathasarathy M; Oldenburg D; Foreman KE; Nickoloff BJ
    Clin Immunol; 2001 Feb; 98(2):280-92. PubMed ID: 11161986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of sex hormones on costimulatory molecule expression in multiple sclerosis.
    Pelfrey CM; Moldovan IR; Cotleur AC; Zamor N; Rudick RA
    J Neuroimmunol; 2005 Oct; 167(1-2):190-203. PubMed ID: 16046001
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dendritic cells from patients with myeloma are numerically normal but functionally defective as they fail to up-regulate CD80 (B7-1) expression after huCD40LT stimulation because of inhibition by transforming growth factor-beta1 and interleukin-10.
    Brown RD; Pope B; Murray A; Esdale W; Sze DM; Gibson J; Ho PJ; Hart D; Joshua D
    Blood; 2001 Nov; 98(10):2992-8. PubMed ID: 11698282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene expression analysis of relapsing-remitting, primary progressive and secondary progressive multiple sclerosis.
    Ratzer R; Søndergaard HB; Christensen JR; Börnsen L; Borup R; Sørensen PS; Sellebjerg F
    Mult Scler; 2013 Dec; 19(14):1841-8. PubMed ID: 24085340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytokine production and surface marker expression in acute and stable multiple sclerosis: altered IL-12 production and augmented signaling lymphocytic activation molecule (SLAM)-expressing lymphocytes in acute multiple sclerosis.
    Ferrante P; Fusi ML; Saresella M; Caputo D; Biasin M; Trabattoni D; Salvaggio A; Clerici E; de Vries JE; Aversa G; Cazzullo CL; Clerici M
    J Immunol; 1998 Feb; 160(3):1514-21. PubMed ID: 9570575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential expression and function of CD80 (B7-1) and CD86 (B7-2) on human peripheral blood monocytes.
    Fleischer J; Soeth E; Reiling N; Grage-Griebenow E; Flad HD; Ernst M
    Immunology; 1996 Dec; 89(4):592-8. PubMed ID: 9014827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcriptional response to interferon beta-1a treatment in patients with secondary progressive multiple sclerosis.
    Gurevich M; Miron G; Falb RZ; Magalashvili D; Dolev M; Stern Y; Achiron A
    BMC Neurol; 2015 Nov; 15():240. PubMed ID: 26589141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced effector and memory CTL responses generated by incorporation of receptor activator of NF-kappa B (RANK)/RANK ligand costimulatory molecules into dendritic cell immunogens expressing a human tumor-specific antigen.
    Wiethe C; Dittmar K; Doan T; Lindenmaier W; Tindle R
    J Immunol; 2003 Oct; 171(8):4121-30. PubMed ID: 14530334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The CD28 related molecule ICOS: T cell modulation in the presence and absence of B7.1/2 and regulational expression in multiple sclerosis.
    Wiendl H; Neuhaus O; Mehling M; Wintterle S; Schreiner B; Mitsdoerffer M; Wienhold W; Weissert R; Wessels J; Hartung HP; Weller M; Tolosa E; Melms A
    J Neuroimmunol; 2003 Jul; 140(1-2):177-87. PubMed ID: 12864987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psoriatic skin-derived dendritic cell function is inhibited by exogenous IL-10. Differential modulation of B7-1 (CD80) and B7-2 (CD86) expression.
    Mitra RS; Judge TA; Nestle FO; Turka LA; Nickoloff BJ
    J Immunol; 1995 Mar; 154(6):2668-77. PubMed ID: 7533180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
    Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
    J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Triggering of murine NK cells by CD40 and CD86 (B7-2).
    Martín-Fontecha A; Assarsson E; Carbone E; Kärre K; Ljunggren HG
    J Immunol; 1999 May; 162(10):5910-6. PubMed ID: 10229827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beta-interferon exposure and onset of secondary progressive multiple sclerosis.
    Zhang T; Shirani A; Zhao Y; Karim ME; Gustafson P; Petkau J; Evans C; Kingwell E; van der Kop M; Zhu F; Oger J; Tremlett H;
    Eur J Neurol; 2015 Jun; 22(6):990-1000. PubMed ID: 25846809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb.
    Lu L; Li W; Zhong C; Qian S; Fung JJ; Thomson AW; Starzl TE
    Transplantation; 1999 Sep; 68(6):747-57. PubMed ID: 10515374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced expression of CD80 (B7-1), CD86 (B7-2), and CD40 and their ligands CD28 and CD154 in fulminant hepatic failure.
    Leifeld L; Trautwein C; Dumoulin FL; Manns MP; Sauerbruch T; Spengler U
    Am J Pathol; 1999 Jun; 154(6):1711-20. PubMed ID: 10362796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. B7-1 (CD80), B7-2 (CD86), interleukin-12 and transforming growth factor-beta mRNA expression in CSF and peripheral blood mononuclear cells from multiple sclerosis patients.
    Monteyne P; Guillaume B; Sindic CJ
    J Neuroimmunol; 1998 Nov; 91(1-2):198-203. PubMed ID: 9846836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.